on 26 Jun 2017
Last Applicant/ Owned by
Medawar Centre
Oxford
GB
OX4 4GA
Serial Number
79045357 filed on 25th Jun 2007
Registration Number
3643630 registered on 23rd Jun 2009
Correspondent Address
PURVI J. PATEL
Filing Basis
No Filing Basis
Disclaimer
NO DATA
Medical services Gene therapy products for medical use, namely, clinical medical reagents, liposome reagents, nucleic acids, and vaccines for use in gene therapy, gene-based medicines, chemotherapeutics, and pharmaceutical preparations for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, bodily conditions associated with impaired immunosystems, singRead More
Chemical products for use in industry and science for use in gene delivery technology and the manufacture of pharmaceuticals and retroviral vector preparations; enzymes for laboratory and research use; chemical products for in vitro use in laboratories and for analysis, namely, for use in gene delivery technology, micro-organisms for laboratory and research use, cell cultures for laboratory and research use, plasmids and cultures of micro-organisms for laboratory and research use, deoxyribonucleic acid sequences for laboratory and research use, cloning vehicles, namely, chemical preparations for scientific purposes for use in biotechnology, research and development and recombinant deoxyribonucleic acid variations thereof for laboratory and research use, all for in vivo use; none of the goods in this class for medical or veterinary purposes; none of the foregoing goods including or for use in connection with the immunoassay diagnostic test devices containing reagent test strips for detecting the presence of drugs of abuse in saliva or urine specimens
Gene therapy products for medical use, namely, clinical medical reagents, liposome reagents, nucleic acids, and vaccines for use in gene therapy, gene-based medicines, chemotherapeutics, and pharmaceutical preparations for use in the treatment of viral and bacterial infections, cancer, HIV and AIDS related infections, bodily conditions associated with impaired immunosystems, single gene disorders, hemophilia, blood disorders, vascular disorders and disorders arising from inappropriate vascularisation, diseases of the nervous system, neuro-degenerative disorders, cardiac disorders, cystic fibrosis, inflammatory and auto-immune diseases; enzymes and enzyme preparations for medical purposes for use in gene delivery technologies; retroviral vector manufacturing preparations and retroviral vector preparations for medical use for gene delivery technologies; chemical products for medical use for genetic engineering and in gene therapy; none of the foregoing goods including or for use in connection with immunoassay diagnostic test devices containing reagent test strips for detecting the presence of drugs of abuse in saliva or urine specimens
Instruments and apparatus for the administration of gene therapy products, namely, injection devices, syringes, scalpels, catheters, tubes for the administration of gene therapy products; surgical and medical apparatus and instruments, namely, injection devices, syringes, scalpels, catheters, tubes for medical services, none being blood circulatory apparatus and instruments, blood pumps, flow probes for blood pumps or blood circulatory devices for medical purposes
Scientific and medical research in the fields of genetic engineering and gene therapy and scientific and medical development in the fields of genetic engineering and gene therapy, genetic engineering services and gene therapy and prophylaxis for the development and commercialization of therapeutic vaccines and gene-based therapies, namely, development of new technology for others in the field of biotechnology, collaboration for others with other biomedical and pharmaceutical entities for the commercialization of therapeutic vaccines and gene-based therapies; none of the foregoing services including or for use in connection with the immunoassay diagnostic test devices containing reagent test strips for detecting the presence of drugs of abuse in saliva or urine specimens
Medical services
No 79045357
No Service Mark
No 21573.tbd
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 11th Jan 2018 | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED |
| 11th Jan 2018 | DEATH OF INTERNATIONAL REGISTRATION |
| 03rd Feb 2017 | TOTAL INVALIDATION PROCESSED BY THE IB |
| 29th Sep 2016 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
| 29th Sep 2016 | INVALIDATION PROCESSED |
| 29th Sep 2016 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
| 29th Jan 2016 | CANCELLED SECTION 71 |
| 12th Jan 2013 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| 28th Sep 2009 | FINAL DISPOSITION PROCESSED |
| 28th Sep 2009 | FINAL DISPOSITION NOTICE SENT TO IB |
